Bio-Techne Releases Fourth Quarter Fiscal 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Bio-Techne Corp. (TECH) PT Raised to $175 at Deutsche Bank
August 8, 2018 7:41 AM EDTDeutsche Bank raised its price target on Bio-Techne Corp. (NASDAQ: TECH) to $175.00 (from $165.00) while maintaining a Hold rating.
... MoreBio-Techne (TECH) Tops Q4 EPS by 5c, Revenues Beat
August 7, 2018 7:04 AM EDTBio-Techne (NASDAQ: TECH) reported Q4 EPS of $1.34, $0.05 better than the analyst estimate of $1.29. Revenue for the quarter came in at $180.3 million versus the consensus estimate of $174.77 million.
Fourth quarter organic revenue increased by 9% (15% reported) to $180.3 million. Full year organic revenues increased by 9% (14% reported) to $643.0 million.GAAP EPS was $1.07 versus $0.74 one year ago, an increase of 45% over the prior year. Full year GAAP EPS was $3.29 versus $2.03 one year ago, an increase of 62% over the prior year.Delivered a record adjusted... More